1. Home
  2. HGBL vs KRON Comparison

HGBL vs KRON Comparison

Compare HGBL & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HGBL
  • KRON
  • Stock Information
  • Founded
  • HGBL 1937
  • KRON 2017
  • Country
  • HGBL United States
  • KRON United States
  • Employees
  • HGBL N/A
  • KRON N/A
  • Industry
  • HGBL Business Services
  • KRON Medicinal Chemicals and Botanical Products
  • Sector
  • HGBL Consumer Discretionary
  • KRON Health Care
  • Exchange
  • HGBL Nasdaq
  • KRON Nasdaq
  • Market Cap
  • HGBL 72.0M
  • KRON 59.1M
  • IPO Year
  • HGBL N/A
  • KRON 2020
  • Fundamental
  • Price
  • HGBL $2.03
  • KRON $0.99
  • Analyst Decision
  • HGBL
  • KRON Buy
  • Analyst Count
  • HGBL 0
  • KRON 3
  • Target Price
  • HGBL N/A
  • KRON $1.63
  • AVG Volume (30 Days)
  • HGBL 101.9K
  • KRON 292.4K
  • Earning Date
  • HGBL 03-13-2025
  • KRON 11-13-2024
  • Dividend Yield
  • HGBL N/A
  • KRON N/A
  • EPS Growth
  • HGBL N/A
  • KRON N/A
  • EPS
  • HGBL 0.27
  • KRON N/A
  • Revenue
  • HGBL $49,878,000.00
  • KRON $9,864,000.00
  • Revenue This Year
  • HGBL N/A
  • KRON $62.21
  • Revenue Next Year
  • HGBL $19.47
  • KRON N/A
  • P/E Ratio
  • HGBL $7.50
  • KRON N/A
  • Revenue Growth
  • HGBL N/A
  • KRON 146.48
  • 52 Week Low
  • HGBL $1.52
  • KRON $0.69
  • 52 Week High
  • HGBL $3.09
  • KRON $1.60
  • Technical
  • Relative Strength Index (RSI)
  • HGBL 70.20
  • KRON 53.69
  • Support Level
  • HGBL $1.92
  • KRON $0.92
  • Resistance Level
  • HGBL $2.12
  • KRON $1.02
  • Average True Range (ATR)
  • HGBL 0.09
  • KRON 0.05
  • MACD
  • HGBL 0.02
  • KRON 0.00
  • Stochastic Oscillator
  • HGBL 79.07
  • KRON 77.38

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a global full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

About KRON Kronos Bio Inc.

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.

Share on Social Networks: